Browse diseases

…fferent patient cohorts of inflammatory bowel disease (IBD) and decompensated cirrhosis, focusing on differences in sociodemographic characteristics.De…

… of 20 (10%) patients with amoebiasis, respectively.Conclusions Parasitic colitis poses a diagnostic challenge in high-income settings. Misdiagno…

…As) and immunomodulators with the risk of CRC and/or dysplasia (CRC/Dys) in different IBD phenotypes.Methods We searched Web of Sci…

… 12-month endoscopic remission rates with infliximab of 56% for ulcerative colitis (UC) and 53% for Crohn’s disease (CD), while a Saudi study repo…

…ing dietary folate and total folate intake may be beneficial in CRC primary prevention. Specifically, folic acid supplements may in…

… consistent test for tracking disease activity in patients with inflammatory bowel disease (IBD) is currently a major challenge. Currently used biomarkers…

…ses the key recommendations for the diagnosis and management of Crohn’s disease from the updated 2025 British Society of Gastroenterology guide…

…ses the key recommendations for the diagnosis and management of ulcerative colitis from the updated 2025 British Society of Gastroenterology guide…

…ed. Disease activity was assessed using the partial Mayo Score (ulcerative colitis) or Harvey-Bradshaw Index (Crohn’s disease). Logistic regressio…

…ited, DAT appears appropriate for selected profiles: refractory IBD with active EIMs, concomitant IMIDs with divergent tissue respo…

…Objective Inflammatory bowel disease (IBD)-associated liver diseases (IBDALDs) are associated with h…

…68), ulcerative colitis (UC) (HR=0.61, 95% CI 0.48 to 0.79) and Crohn’s disease (HR=0.49, 95% CI 0.36 to 0.67), and 18.9% of the reduced risk w…